Mabswitch was awarded the Bristol Myers Squibb Golden Ticket. The award provides one year of fully paid individual laboratory bench space and membership at BioLabs@NYULangone, a fully equipped, laboratory-based incubator in Manhattan with facilities, support and equipment designed to accelerate early-stage startups in the life sciences and biopharma spaces.
Mabswitch is deeply honored and excited to be awarded a Bristol Myers Squibb Golden Ticket. This award of free lab space at the prestigious Biolabs@NYULangone by one of the global leaders in cancer immunotherapy further reinforces our efforts and commitment to develop the next generation of antibody-based immunotherapies that will be regulatable and precisely tunable to each individual patients needs, thus maximizing the therapeutic benefits, whilst minimizing adverse side-effects. Together we will go one step closer to curing cancers, autoimmune diseases and other chronic conditions that currently have few or, no other suitable therapeutic options.Dr Yemi Onakunle, CEO Mabswitch